At Canadian Medical, we have started administering Beyfortus®, which helps protect infants and young children against respiratory syncytial virus (RSV). RSV can cause serious respiratory infections in infants, such as bronchiolitis, and is one of the common causes of hospitalisation in young children.
Beyfortus® is administered as a single injection and provides protection throughout the RSV season, which typically lasts from October to March.
For children born on or after 1 April 2026, this protection is fully covered by public health insurance during their first RSV season.
If you are interested, please book an appointment through our client line at 222 300 300.
Articles and news
Article
Canadian Medical partners with Alžběta Jungrová’s exhibition and new book
News
Canadian Medical becomes a partner of the 60th KVIFF
News
Outpatient varicose vein surgery
News
Do you want to learn how to correctly provide first aid to your child?
News
Changes to Canadian Medical Terms and Conditions for individual clients
News
Notice: Andes hantavirus
News
Modern treatment of venous diseases
News
Summer without health complications: What to watch out for and how to provide first aid